基于液相色谱串联质谱技术的喹硫平试剂盒临床一致性评价

励璇玮; 林美花; 翟优; 徐娜娜; 李潇; 吕朵; 赵青威; 刘健

doi:10.13748/j.cnki.issn1007-7693.20230211

基于液相色谱串联质谱技术的喹硫平试剂盒临床一致性评价

Clinical Consistency Evaluation of Quetiapine Kit Based on Liquid Chromatography Tandem Mass Spectrometry Technology

摘要

摘要:
目的评价喹硫平液相色谱串联质谱试剂盒与实验室自建方法(参比方法)在喹硫平治疗药物监测平台中检测结果的一致性。
方法收集2021年3月—10月在浙江大学医学院附属第一医院进行喹硫平治疗药物监测的120例患者的临床检测剩余血浆标本，分别用试剂盒方法与参比方法检测其喹硫平血药浓度。对检测结果进行离群值分析，线性回归评价其相关性，Bland-Altman法评价其一致性。
结果检测结果无离群值；线性回归方程为Y=1.018X+4.400，r=0.998，相关性良好；Bland-Altman图显示一致性良好。
结论喹硫平液相色谱串联质谱试剂盒与参比方法检测结果一致性良好，可用于临床喹硫平治疗药物监测。

Abstract:
OBJECTIVE To evaluate the consistency between the quetiapine LC-MS/MS kit and the laboratory-built method(reference method) in the detection results of quetiapine therapeutic drug monitoring.
METHODS A total of 120 remaining plasma samples were collected from patients receiving quetiapine therapeutic drug monitoring from March to October in 2021. The plasma concentration of quetiapine was detected by kit and reference method respectively. The analysis of correlations and consistency was performed by outlier analysis, linear regression and Bland-Altman method.
RESULTS No outliers were detected. The linear regression equation was Y=1.018X+4.400(r=0.998), indicating a good correlation. The Bland-Altman plot analysis showed good agreement between the two measurements.
CONCLUSION The detection results of quetiapine LC-MS/MS kit and reference method are in good agreement. The kit can be used for clinical quetiapine treatment drug monitoring.

HTML全文

参考文献(10)

施引文献

资源附件(0)